Register for free to listen to this article
Listen with Speechify
0:00
2:00
Shimadzu Scientific Instruments Inc.
Shimadzu Scientific Instruments has taken the wraps offseveral new products, including AXIMA MegaTOF, an integrated MALDI solutionfrom Shimadzu and CovalX for ultra high-mass applications that detect intactcomplexes up to 1.5 MDa.; Nexera Ultra High-Performance Liquid Chromatograph,which meets all analysis requirements with no compromise in data integrity;Nanotrap Biomarker Discovery Platform, which gives researchers the ability toenrich, preserve and screen low-level biomarkers directly from complexbiological samples; and Component ID Solution, software that accelerateshigh-confidence component identification using the power of high-mass accuracyand the simplicity of an open-access workflow.

Shimadzu Scientific Instruments Inc.

(410) 381-1222

www.ssi.shimadzu.com

 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue